Get 20% lifetime commission for referring investors to digrin.com
here.
Entrada Therapeutics, Inc. ( TRDA) - Stock Earnings
TRDA Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
TRDA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -39.2 million USD | 1.3 million USD |
| 2026Q1 | -39.7 million USD | 875000 USD |
| 2026Q2 | -42.8 million USD | 898000 USD |
| 2027Q2 Est. | — | — |
TRDA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -6.7 million USD | 129.0 million USD |
| 2024 | 65.6 million USD | 210.8 million USD |
| 2025 | -143.8 million USD | 25.4 million USD |
| 2026 Est. | — | — |
TRDA
Price: $4.37
52 week price:
Earnings Per Share: -4.01 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 22900
Market Capitalization: 201.9 million